semaglutide and hypothyroidism Semaglutide-induced Subclinical Hypothyroidism: A Case

Common nutritional concerns associated with GLP-1 therapy may include: Reduced appetite and inadequate nutrient intake Loss of lean muscle mass during rapid weight reduction Nausea, digestive discomfort, and poor food tolerance Fatigue and reduced energy levels Micronutrient deficiencies over long-term use Increased nutritional needs in patients with complex clinical conditions Effective GLP-1 treatment requires more than medication alone

Here's how to spot them.

Safran SafrInside : Saffron, derived from the stigmas of the Crocus sativus flower, is a precious spice renowned for its unique properties

Clinical trials show semaglutide users lose an average of 10-15% of body weight over 68 weeks, with some patients achieving losses exceeding 20%

Eli Lilly (NYSE:LLY) reported Phase 3 results for obesity drugs retatrutide and Foundayo at the American Diabetes Association 86th Scientific Sessions in 2026